We have introduced two endoscopic treatments for early gastric cancer: endoscopic mucosal resection using a cap-fitted panendoscope (EMRC), and endoscopic laser therapy using a Nd-YAG laser. Thirty-two patients (34 lesions) with gastric cancer were treated by Nd-YAG laser; including 23 initial-therapy cases (25 lesions) and 9 second-therapy cases representing failmes ofendoscopic mucosal resection or endoscopic ethanol injection. Endoscopic laser therapy was performed safely without complication in all patients. Three patients had residual cancer, and 2 of these required surgery. Six patients died from other disease. Endoscopic laser therapy can remove early gastric cancer even when the lesion has ulceration or submucosal invasion, and has a powerful hemostatic effect.
INTRODUCTION
Neodymium yttrium aluminum garnet (Nd-YAG) laser treatment has been used to alleviate obstruction from unresectable malignant lesions of the gastrointestinal tract [1] , to arrest hemorrhage from gastric vascular ectasia [2] , and to treat early gastric cancer curatively [3] .
Curative endoscopic treatment for early gastric cancer has become accepted at many institutions in Japan, incorporating such specific modalities as polypectomy, mucosal resection (EMR), laser, heatprobe, microwave, injections and hyperthermia. We have introduced two endoscopic treatments for early gastric cancer. The first is an endoscopic mucosal resection using a cap-fitted panendoscope (EMRC) [4] [5] [6] . The second is a laser therapy using a medical Nd-YAG laser system (MC2100) [7] .
We examined our results with endoscopic laser therapy and evaluated its role in the endoscopic treatment of early gastric cancer. [8] . We performed laser irradiation using a transparent EMRC cap as Ozaki's method [9] . An EMRC cap (transparent plastic hood; Fig. 2a ) was fitted to the tip of the endoscope and the laser fiber was passed through the biopsy channel (Fig. 2b) . Using the cap, we obtained a good view in a variety of lesion sites and maintained the necessary distance between the laser fiber and the lesion during irradiation.
MATERIALS AND METHODS

Indication
Follow-up
We medicated all patients with H2-blockers and sucralfate (mucosa-protecting drugs) for 1 month after treatment. Endoscopic examination and pathological examination of biopsy specimens were performed 1, 3, 6, 9 and 12 months after treatment, and then twice a year.
FIGURE 2b An EMRC cap (transparent plastic hood) is fitted to the tip of the panendoscope, and the laser fiber is passed through the biopsy channel.
RESULTS
Twenty-four in 32 patients were treated on an ambulatory basis with endoscopic laser therapy. Eight patients were treated as inpatients. Fifteen of the 34 lesions were laser-irradiated once, and 19 lesions were irradiated more than once. Two patients with a total of these lesions had laser therapy because EMR was contraindicated. One was a patient with a pacemaker for whom it was not safe to use high-frequency electr0cautery, and another was a hemodialysis patient with liver cirrhosis and hypocoagulability. 
Complications
We experienced no complications in 32 cases of endoscopic laser therapy using the medical YAG laser system MC2100. Illustrative Case Figure 3 shows a case of residual cancer following EMRC in a 72-year-old man. A biopsy specimen from a small reddish area of the edge of the scar revealed adenocarcinoma (Fig. 3a) . We performed endoscopic laser irradiation using an EMRC cap with the MC2100 (non-contact method, continuous wave, 1.32-1xm wavelength, 20 watts, and 510 joules). Because the lesion was located in the upper gastric body on the lesser curvature, only an oblique view of the lesion was obtained by usual endoscopic examination. The EMRC cap at the tip of the endoscope allowed a front view of the lesion, and vertical laser irradiation was performed (Fig. 3b) . The patient was cancer-free 27 months following laser therapy (Fig. 3c) .
Nd-YAG LASER FOR EARLY GASTRIC CANCER 207 One of the two operative cases was an 80-year-old man with residual cancer following EMR at another center. Cancer remained following five treatments with laser therapy; we therefore performed a gastric resection. Macroscopic findings in the resected stomach were a small tumor in the whitish area (Fig. 4a) . Histological examination ofthe irradiated area revealed cancer cells remained in the mucosal layer. Almost all of the submucosa was replaced by fibrosis (Fig. 4b) .
DISCUSSION
Endoscopic laser therapy has several roles in the treatment of gastric cancer including alleviation of stenosis in advanced cases, hemostasis, and curative treatment in early disease.
Gastric mucosal cancers rarely demonstrate lymph node metastasis, and it is widely accepted in Japan that small gastric mucosal cancers without lymph node metastasis can be curatively treated endoscopically. Single early gastric cancers resected at our department were retrospectively analyzed with regard to the depth of invasion and the incidence of lymph node metastasis [10] . R e s e c t i o n / l e s i o n s C a p ' f i t t e d w i t h P a n e n d s c P e u l c e r 
